CN109007224A - A kind of pressed candy and preparation method thereof containing Astaxanthin In Haematococcus Pluvialis conditioning female organism - Google Patents
A kind of pressed candy and preparation method thereof containing Astaxanthin In Haematococcus Pluvialis conditioning female organism Download PDFInfo
- Publication number
- CN109007224A CN109007224A CN201811202442.9A CN201811202442A CN109007224A CN 109007224 A CN109007224 A CN 109007224A CN 201811202442 A CN201811202442 A CN 201811202442A CN 109007224 A CN109007224 A CN 109007224A
- Authority
- CN
- China
- Prior art keywords
- weight
- parts
- powder
- haematococcus pluvialis
- pressed candy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000168517 Haematococcus lacustris Species 0.000 title claims abstract description 45
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 title claims abstract description 38
- 235000013793 astaxanthin Nutrition 0.000 title claims abstract description 38
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 title claims abstract description 38
- 229940022405 astaxanthin Drugs 0.000 title claims abstract description 38
- 239000001168 astaxanthin Substances 0.000 title claims abstract description 38
- 235000009508 confectionery Nutrition 0.000 title claims abstract description 23
- 230000003750 conditioning effect Effects 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 239000000843 powder Substances 0.000 claims abstract description 104
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 30
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 30
- 241000195493 Cryptophyta Species 0.000 claims abstract description 17
- 102000008186 Collagen Human genes 0.000 claims abstract description 15
- 108010035532 Collagen Proteins 0.000 claims abstract description 15
- 240000000902 Diospyros discolor Species 0.000 claims abstract description 15
- 235000003115 Diospyros discolor Nutrition 0.000 claims abstract description 15
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims abstract description 15
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims abstract description 15
- 240000001717 Vaccinium macrocarpon Species 0.000 claims abstract description 15
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 claims abstract description 15
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims abstract description 15
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 claims abstract description 15
- 235000021014 blueberries Nutrition 0.000 claims abstract description 15
- 235000004634 cranberry Nutrition 0.000 claims abstract description 15
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 15
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims abstract description 15
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 claims abstract description 14
- WVXRAFOPTSTNLL-NKWVEPMBSA-N 2',3'-dideoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO)O1 WVXRAFOPTSTNLL-NKWVEPMBSA-N 0.000 claims abstract description 14
- 240000003394 Malpighia glabra Species 0.000 claims abstract description 14
- 235000014837 Malpighia glabra Nutrition 0.000 claims abstract description 14
- 239000000905 isomalt Substances 0.000 claims abstract description 14
- 235000010439 isomalt Nutrition 0.000 claims abstract description 14
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 claims abstract description 14
- 241000167854 Bourreria succulenta Species 0.000 claims abstract description 13
- 235000019693 cherries Nutrition 0.000 claims abstract description 13
- 229920001202 Inulin Polymers 0.000 claims abstract description 11
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 11
- 229940029339 inulin Drugs 0.000 claims abstract description 11
- 239000001509 sodium citrate Substances 0.000 claims abstract description 11
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims abstract description 11
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 32
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 32
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 32
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 32
- 239000000080 wetting agent Substances 0.000 claims description 31
- 235000020985 whole grains Nutrition 0.000 claims description 26
- 239000002245 particle Substances 0.000 claims description 20
- 239000000463 material Substances 0.000 claims description 19
- 240000000851 Vaccinium corymbosum Species 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- 238000001035 drying Methods 0.000 claims description 10
- 238000010348 incorporation Methods 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 8
- 238000005469 granulation Methods 0.000 claims description 8
- 230000003179 granulation Effects 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 3
- 244000144730 Amygdalus persica Species 0.000 claims 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 235000006040 Prunus persica var persica Nutrition 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 238000005303 weighing Methods 0.000 claims 1
- 235000013305 food Nutrition 0.000 abstract description 15
- 206010010774 Constipation Diseases 0.000 abstract description 5
- 230000036541 health Effects 0.000 abstract description 5
- 230000009286 beneficial effect Effects 0.000 abstract description 4
- 230000036039 immunity Effects 0.000 abstract description 4
- 230000000968 intestinal effect Effects 0.000 abstract description 4
- 230000014860 sensory perception of taste Effects 0.000 abstract description 4
- 230000001934 delay Effects 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 230000009758 senescence Effects 0.000 abstract description 3
- 244000077233 Vaccinium uliginosum Species 0.000 abstract description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 16
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 8
- 229930003268 Vitamin C Natural products 0.000 description 8
- 235000019154 vitamin C Nutrition 0.000 description 8
- 239000011718 vitamin C Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 5
- 241000723353 Chrysanthemum Species 0.000 description 4
- 235000007516 Chrysanthemum Nutrition 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 235000013406 prebiotics Nutrition 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- OQUFOZNPBIIJTN-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;sodium Chemical compound [Na].OC(=O)CC(O)(C(O)=O)CC(O)=O OQUFOZNPBIIJTN-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- -1 iron ion Chemical class 0.000 description 3
- 230000035790 physiological processes and functions Effects 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 238000009736 wetting Methods 0.000 description 3
- 241000167880 Hirundinidae Species 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 125000000468 ketone group Chemical group 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 241000143060 Americamysis bahia Species 0.000 description 1
- 108060006004 Ascorbate peroxidase Proteins 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010022678 Intestinal infections Diseases 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- SNIXRMIHFOIVBB-UHFFFAOYSA-N N-Hydroxyl-tryptamine Chemical compound C1=CC=C2C(CCNO)=CNC2=C1 SNIXRMIHFOIVBB-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 241000081271 Phaffia rhodozyma Species 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 241000555745 Sciuridae Species 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000007366 host health Effects 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 150000004715 keto acids Chemical class 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/42—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds characterised by the carbohydrates used, e.g. polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention discloses a kind of pressed candy and preparation method thereof containing Astaxanthin In Haematococcus Pluvialis conditioning female organism, the components including following parts by weight: haematococcus pluvialis algae powder 5.0~15.0;Isomalt 15.0~40.0;Collagen protein powder 5~30.0;Butter fruit powder 1.0~10.0;Acerola cherry fruit powder 1.0~10.0;Cranberry fruit powder 1.0~10.0;Blueberry powder 1.0~10.0;Oligofructose 5.0~20.0;Stachyose 0.5~5.0;Inulin 0.5~5.0;Sodium citrate 0.1~0.5;Magnesium stearate 0.1~1.5;The present invention has strengthen immunity, delays senescence, and removes the internal harmful free radicals in part, quickly adjusts intestinal microecology, improves constipation, meets modern female consumption demand, be easy to receive;Abundant Astaxanthin In Haematococcus Pluvialis food products market simultaneously, is providing consumer food for consumer, enriches the sense of taste and vision;Both meet the consumer psychology of consumer, and be also beneficial to consumer's own health after edible.And preparation step is simple, it is easy to industrialized production.
Description
Technical field
Invention belongs to food processing technology field, and in particular to one kind improves female organism containing Astaxanthin In Haematococcus Pluvialis
Pressed candy and preparation method thereof.
Background technique
Astaxanthin is a kind of carotenoid in source keto-acid non-vitamin A.Because there is astaxanthin coloring, anti-oxidant, light to protect
Shield promotes the multiple biological functions such as immune, the maintenance central nervous system health of breeding, enhancing, deep in recent years to be eaten both at home and abroad
The concern of the industries such as product, medicine, cosmetics, aquaculture.Astaxanthin mainly passes through chemical synthesis and by extracting in natural materials
And it obtains.Chemical synthesis astaxanthin is very limited due to its safety issue in application aspect.Natural astaxanthin mainly comes
Source organism has: shellfish (such as shrimps), algae (such as haematococcus pluvialis and fungi such as phaffia rhodozyma).Astaxanthin chemistry
Entitled -4,4 '-diketo-β, β '-carrotene of 3,3 '-dihydroxy.There are conjugated double bond, terminal ring structures in astaxanthin molecule
Present on the alpha-alcohol ketone that is constituted of hydroxyl and unsaturated ketone group and hydroxyl and ketone group be that astaxanthin has various biology
The main reason for function.
Vitamin is a kind of trace organic substance that artificially maintains normal physiological function and must obtain from food,
Growth in humans, metabolism play an important role in growth course.And wherein vitamin C is a kind of most unstable vitamin,
Since it is oxidized easily, vitamin C can be destroyed in food storage or gastronomical process, or even when chopping fresh vegetables.
Micro copper, iron ion can accelerate the speed destroyed.Vitamin C is that antibody and collagen are formed, tissue repairing (including certain oxidations
Reduction), the metabolism of phenylalanine, tyrosine, folic acid, the utilization of iron, carbohydrate, the synthesis of fat, protein, dimension
Immune function, hydroxylation and hydroxytryptamine are held, the complete of blood vessel is kept, promotes the institute such as nonheme iron absorption required, while vitamin C
It has been also equipped with anti-oxidant, free radical resisting, has inhibited the formation of tyrosinase, to reach whitening, the effect of light spot.In human body,
Vitamin C is high-efficiency antioxidant agent, for mitigating the oxidation stress of ascorbate peroxidase enzyme substrate.There are many more important
Vitamin C participation effect is also required in biosynthetic process.But a small number of animals such as the mankind, primate, marmot but cannot be certainly
Body synthesis, it is necessary to by food, drug etc. absorb, therefore vitamin C maintain human normal physiological function take on it is important
Role.
Prebiotics are a kind of dietary supplements, pass through the growth for stimulating the bacterium in a kind of or a small number of kind of bacterium colonies of selectivity
With activity to host's generation wholesome effect so as to improve the food composition that can not be digested of host health.Prebiotics are logical
It is most of not to be digested and be fermented by intestinal flora when crossing upper digestive tract.Most importantly it only stimulates profitable strain
Growth, rather than have potential pathogenic or corrupt active harmful bacteria.Currently, prebiotics mainly have several effects:
1) increase enterocinesia, reduce constipation;2) prevent enteric infection, inhibit diarrhea;3) promote being absorbed and utilized for calcium, reduce osteoporosis
The disease incidence of disease;4) triglycerides and cholesterol level are reduced, atherosclerosis and cardiovascular disease are reduced;5) alleviate pancreas islet
Plain antagonism reduces obesity and diabetes B;6) disease incidence of cancer is reduced.
More and more women improve the consciousness of Care for themselves, self-protection, are especially focused in autoimmunity, body
The adjusting of healthy aspect.In view of the powerful physiological function of Astaxanthin In Haematococcus Pluvialis, by it with vitamin C, prebiotics are combined makes
With, it is applied to field of food, develops the food of a Astaxanthin In Haematococcus Pluvialis, meanwhile, it enriches Astaxanthin In Haematococcus Pluvialis and produces
Product market.
Summary of the invention
The present invention has strengthen immunity in order to solve the above technical problems, providing one kind, delays senescence, and it is internal to remove part
Harmful free radicals quickly adjust intestinal microecology, improve constipation, Scavenging activity of the enhancing body to cell rubbish;It enriches simultaneously
Astaxanthin In Haematococcus Pluvialis food products market is providing consumer food for consumer, enriches the sense of taste and vision;Both met consumer's
Consumer psychology is also beneficial to the tabletting containing Astaxanthin In Haematococcus Pluvialis conditioning female organism of consumer's own health after edible
Candy.
The purpose of the present invention is what is be achieved through the following technical solutions:
A kind of pressed candy containing Astaxanthin In Haematococcus Pluvialis conditioning female organism, the component including following parts by weight:
The pressed candy containing Astaxanthin In Haematococcus Pluvialis conditioning female organism as a preferred technical solution,
Component including following parts by weight:
The pressed candy containing Astaxanthin In Haematococcus Pluvialis conditioning female organism is prepared the present invention also provides a kind of
Method, comprising steps of
1) the hydroxypropyl methyl cellulose wetting agent that mass fraction is 0.5%~2.0% is prepared;
2) weigh the haematococcus pluvialis algae powder of 5.0~15.0 parts by weight, the isomalt of 15.0~40.0 parts by weight,
The acerola concentrate of the collagen protein powder of 5~30.0 parts by weight, the butter fruit powder of 1.0~10.0 parts by weight, 1.0~10.0 parts by weight
Fruit powder, the Cranberry fruit powder of 1.0~10.0 parts by weight, the blueberry powders of 1.0~10.0 parts by weight, 5.0~20.0 parts by weight
Oligofructose, the stachyose of 0.5~5.0 parts by weight, the inulin of 0.5~5.0 parts by weight, 0.1~0.5 parts by weight citric acid
Sodium crosses 80 mesh standard sieves, after mixing, hydroxypropyl methyl cellulose wetting agent, hydroxypropyl methyl cellulose wetting is added
Agent dosage is 10~30 parts by weight, is uniformly mixed;
3) material being uniformly mixed is granulated;
4) particle prepared vacuum oven is put into dry;
5) by the dry powder collection completed, whole grain is carried out;
6) magnesium stearate of 0.1~1.5 parts by weight is weighed, and the particle completed with whole grain is mixed, incorporation time
10min~15min;
7) material mixed is put into tablet press machine, pressure is 40~70KN, carries out tabletting.
The haematococcus pluvialis algae powder of 8.0~12.0 parts by weight is weighed as a preferred technical solution,;20.0~30.0 weight
The isomalt of part;The collagen protein powder of 10~20.0 parts by weight, the butter fruit powder of 3.0~8.0 parts by weight, 3.0~8.0
The Acerola cherry fruit powder of parts by weight, the Cranberry fruit powder of 3.0~8.0 parts by weight, the blueberry powder of 3.0~8.0 parts by weight, 10.0
The oligofructose of~15.0 parts by weight, the stachyose of 2.0~4.0 parts by weight, the inulin of 2.0~4.0 parts by weight, 0.2~0.3 weight
Measure the sodium citrate of part, the magnesium stearate of 0.5~1.2 parts by weight.
As a preferred technical solution, the hydroxypropyl methyl cellulose wetting agent solvent in the step 1) be 50%~
90% ethanol-water system.
The granulation in the step 3) uses 20 mesh standard sieves as a preferred technical solution,.
As a preferred technical solution, the drying temperature in the step 4) be 50~80 DEG C, pressure be -0.09MPa~-
0.05MPa, 2~6h of time.
The whole grain in the step 5) uses 20 mesh standard sieves as a preferred technical solution,.
Tabletting slice weight is 0.4~0.8g/ piece in the step 7) as a preferred technical solution,.
The eating method of the above-mentioned pressed candy containing Astaxanthin In Haematococcus Pluvialis conditioning female organism: one after each meal is chewed
It takes or swallows.It is recommended that daily intaking amount 1~2.
Advantages of the present invention:
The present invention has strengthen immunity, delays senescence, and removes the internal harmful free radicals in part, quickly adjusts the micro- life of enteron aisle
State improves constipation, meets modern female consumption demand, be easy to receive;Abundant Astaxanthin In Haematococcus Pluvialis food products market simultaneously,
Consumer food is provided for consumer, enriches the sense of taste and vision;Both the consumer psychology of consumer had been met, and had been also beneficial to consume after edible
Person's own health.And preparation step is simple, it is easy to industrialized production.
By adopting the above-described technical solution, a kind of pressed candy containing Astaxanthin In Haematococcus Pluvialis conditioning female organism
And preparation method thereof, the component including following parts by weight: haematococcus pluvialis algae powder 5.0~15.0;Isomalt 15.0~
40.0;Collagen protein powder 5~30.0;Butter fruit powder 1.0~10.0;Acerola cherry fruit powder 1.0~10.0;Cranberry fruit powder 1.0
~10.0;Blueberry powder 1.0~10.0;Oligofructose 5.0~20.0;Stachyose 0.5~5.0;Inulin 0.5~5.0;Citric acid
Sodium 0.1~0.5;Magnesium stearate 0.1~1.5;The present invention removes the internal nocuousness in part certainly with strengthen immunity, anti-aging
By base, intestinal microecology is quickly adjusted, improves constipation, meets modern female consumption demand, be easy to receive;Abundant rain life is red simultaneously
Ball algae astaxanthin food market, is providing consumer food for consumer, enriches the sense of taste and vision;Both the consumption heart of consumer had been met
Reason is also beneficial to consumer's own health after edible.And preparation step is simple, it is easy to industrialized production.
Specific embodiment
The present invention will be further described below with reference to examples, but protection scope of the present invention is not limited solely to implement
Example.
A kind of pressed candy containing Astaxanthin In Haematococcus Pluvialis conditioning female organism, the component including following parts by weight:
The pressed candy containing Astaxanthin In Haematococcus Pluvialis conditioning female organism, the group including following parts by weight
Point:
A method of preparing the pressed candy containing Astaxanthin In Haematococcus Pluvialis conditioning female organism, including step
It is rapid:
1) the hydroxypropyl methyl cellulose wetting agent that mass fraction is 0.5%~2.0% is prepared;
2) weigh the haematococcus pluvialis algae powder of 5.0~15.0 parts by weight, the isomalt of 15.0~40.0 parts by weight,
The acerola concentrate of the collagen protein powder of 5~30.0 parts by weight, the butter fruit powder of 1.0~10.0 parts by weight, 1.0~10.0 parts by weight
Fruit powder, the Cranberry fruit powder of 1.0~10.0 parts by weight, the blueberry powders of 1.0~10.0 parts by weight, 5.0~20.0 parts by weight
Oligofructose, the stachyose of 0.5~5.0 parts by weight, the inulin of 0.5~5.0 parts by weight, 0.1~0.5 parts by weight citric acid
Sodium crosses 80 mesh standard sieves, after mixing, hydroxypropyl methyl cellulose wetting agent, hydroxypropyl methyl cellulose wetting is added
Agent dosage is 10~30 parts by weight, is uniformly mixed;
3) material being uniformly mixed is granulated;
4) particle prepared vacuum oven is put into dry;
5) by the dry powder collection completed, whole grain is carried out;
6) magnesium stearate of 0.1~1.5 parts by weight is weighed, and the particle completed with whole grain is mixed, incorporation time
10min~15min;
7) material mixed is put into tablet press machine, pressure is 40~70KN, carries out tabletting.
Weigh the haematococcus pluvialis algae powder of 8.0~12.0 parts by weight;The isomalt of 20.0~30.0 parts by weight;10
The collagen protein powder of~20.0 parts by weight, the butter fruit powder of 3.0~8.0 parts by weight, the Acerola cherry fruit of 3.0~8.0 parts by weight
Powder, the Cranberry fruit powder of 3.0~8.0 parts by weight, the blueberry powder of 3.0~8.0 parts by weight, 0.0~15.0 parts by weight it is oligomeric
Fructose, the stachyose of 2.0~4.0 parts by weight, the inulin of 2.0~4.0 parts by weight, the sodium citrate of 0.2~0.3 parts by weight, 0.5
The magnesium stearate of~1.2 parts by weight.
The ethanol-water system that hydroxypropyl methyl cellulose wetting agent solvent in the step 1) is 50%~90%.
Granulation in the step 3) uses 20 mesh standard sieves.
Drying temperature in the step 4) is 50~80 DEG C, and pressure is -0.09MPa~-0.05MPa, 2~6h of time.
Whole grain in the step 5) uses 20 mesh standard sieves.
Tabletting slice weight is 0.4~0.8g/ piece in the step 7).
The eating method of the above-mentioned pressed candy containing Astaxanthin In Haematococcus Pluvialis conditioning female organism: one after each meal is chewed
It takes or swallows.It is recommended that daily intaking amount 1~2.
Embodiment 1:
Weigh haematococcus pluvialis algae powder 20.0g, isomalt 57.4g, collagen protein powder 5.0g, butter fruit powder
2.0g, Acerola cherry fruit powder 2.0g, Cranberry fruit powder 2.0g, blueberry powder 2.0g, oligofructose 5.0g, stachyose 2.0g, chrysanthemum
The alcohol-water for the hydroxypropyl methyl cellulose that mass fraction is 1.0% is added in powder 2.0g, sodium citrate 0.1g after mixing
Wetting agent, concentration of alcohol 75%, about 15g, is thoroughly mixed, and is granulated with 20 mesh of standard screen cloth;Particle is put into
Vacuum oven is dried, and temperature 70 C, time 4.0h, pressure -0.075MPa is arranged;The powder collection that drying is completed,
It is spare with 20 mesh standard sieve net whole grains;It weighs magnesium stearate 0.5g and is mixed with spare particle, incorporation time 10min;
The material mixed is put into tablet press machine, adjustment slice weight is 0.6g, pressure 50KN, carries out tabletting.
Embodiment 2:
Weigh haematococcus pluvialis algae powder 30.0g, isomalt 28.2.4g, collagen protein powder 10.0g, butter fruit powder
5.0g, Acerola cherry fruit powder 5.0g, Cranberry fruit powder 5.0g, blueberry powder 5.0g, oligofructose 5.0g, stachyose 3.0g, chrysanthemum
The alcohol-water for the hydroxypropyl methyl cellulose that mass fraction is 2.0% is added in powder 3.0g, sodium citrate 0.3g after mixing
Wetting agent, concentration of alcohol 70%, about 20g, is thoroughly mixed, and is granulated with 20 mesh of standard screen cloth;Particle is put into
Vacuum oven is dried, and is arranged 65 DEG C of temperature, time 5.0h, pressure -0.075MPa;The powder collection that drying is completed,
It is spare with 20 mesh standard sieve net whole grains;It weighs magnesium stearate 0.5g and is mixed with spare particle, incorporation time 10min;
The material mixed is put into tablet press machine, adjustment slice weight is 0.5g, pressure 60KN, carries out tabletting.
Embodiment 3:
1) the hydroxypropyl methyl cellulose wetting agent that mass fraction is 0.5% is prepared;
2) weigh the haematococcus pluvialis algae powder of 5.0 parts by weight, the isomalt of 15.0 parts by weight, 5 parts by weight glue
Former albumen powder, the butter fruit powder of 1.0 parts by weight, the Acerola cherry fruit powder of 1.0 parts by weight, the Cranberry fruit powder of 1.0 parts by weight,
The blueberry powder of 1.0 parts by weight, the oligofructose of 5.0 parts by weight, the stachyose of 0.5 parts by weight, the inulin of 0.5 parts by weight, 0.1
The sodium citrate of parts by weight crosses 80 mesh standard sieves, after mixing, hydroxypropyl methyl cellulose wetting agent, hydroxypropyl is added
Methylcellulose wetting agent dosage is 10 parts by weight, is uniformly mixed;
3) material being uniformly mixed is granulated;
4) particle prepared vacuum oven is put into dry;
5) by the dry powder collection completed, whole grain is carried out;
6) magnesium stearate of 0.1 parts by weight is weighed, and the particle completed with whole grain is mixed, incorporation time 10min;
7) material mixed is put into tablet press machine, pressure is 40~70KN, carries out tabletting.
The ethanol-water system that hydroxypropyl methyl cellulose wetting agent solvent in the step 1) is 50%.
Granulation in the step 3) uses 20 mesh standard sieves.
Drying temperature in the step 4) is 50 DEG C, and pressure is -0.09MPa, 2~6h of time.
Whole grain in the step 5) uses 20 mesh standard sieves.
Tabletting slice weight is 0.4g/ piece in the step 7).
Embodiment 4:
1) the hydroxypropyl methyl cellulose wetting agent that mass fraction is 1.0% is prepared;
2) the haematococcus pluvialis algae powder of 10.0 parts by weight, the isomalt of 25.0 parts by weight, 18.0 parts by weight are weighed
Collagen protein powder, the butter fruit powders of 5.0 parts by weight, the Acerola cherry fruit powder of 5.0 parts by weight, 5.0 parts by weight Cranberry fruit
Powder, the blueberry powder of 5.0 parts by weight, the oligofructose of 10.0 parts by weight, the stachyose of 3.0 parts by weight, 3.0 parts by weight chrysanthemum
The sodium citrate of powder, 0.3 parts by weight crosses 80 mesh standard sieves, after mixing, hydroxypropyl methyl cellulose wetting agent is added,
Hydroxypropyl methyl cellulose wetting agent dosage is 20 parts by weight, is uniformly mixed;
3) material being uniformly mixed is granulated;
4) particle prepared vacuum oven is put into dry;
5) by the dry powder collection completed, whole grain is carried out;
6) magnesium stearate of 1.0 parts by weight is weighed, and the particle completed with whole grain is mixed, incorporation time 12min;
7) material mixed is put into tablet press machine, pressure 55KN carries out tabletting.
The ethanol-water system that hydroxypropyl methyl cellulose wetting agent solvent in the step 1) is 65%.
Granulation in the step 3) uses 20 mesh standard sieves.
Drying temperature in the step 4) is 65 DEG C, and pressure is -0.07MPa, 2~6h of time.
Whole grain in the step 5) uses 20 mesh standard sieves.
Tabletting slice weight is 0.6g/ piece in the step 7).
Embodiment 5:
1) the hydroxypropyl methyl cellulose wetting agent that mass fraction is 2.0% is prepared;
2) the haematococcus pluvialis algae powder of 15.0 parts by weight, the isomalt of 40.0 parts by weight, 30.0 parts by weight are weighed
Collagen protein powder, the butter fruit powders of 10.0 parts by weight, the Acerola cherry fruit powder of 10.0 parts by weight, 10.0 parts by weight Cranberry
Fruit powder, the blueberry powder of 10.0 parts by weight, the oligofructose of 20.0 parts by weight, the stachyose of 5.0 parts by weight, 5.0 parts by weight
The sodium citrate of inulin, 0.5 parts by weight crosses 80 mesh standard sieves, after mixing, hydroxypropyl methyl cellulose wetting is added
Agent, hydroxypropyl methyl cellulose wetting agent dosage are 30 parts by weight, are uniformly mixed;
3) material being uniformly mixed is granulated;
4) particle prepared vacuum oven is put into dry;
5) by the dry powder collection completed, whole grain is carried out;
6) magnesium stearate of 1.5 parts by weight is weighed, and the particle completed with whole grain is mixed, incorporation time 15min;
7) material mixed is put into tablet press machine, pressure 70KN carries out tabletting.
The ethanol-water system that hydroxypropyl methyl cellulose wetting agent solvent in the step 1) is 90%.
Granulation in the step 3) uses 20 mesh standard sieves.
Drying temperature in the step 4) is 80 DEG C, and pressure is -0.05MPa, 2~6h of time.
Whole grain in the step 5) uses 20 mesh standard sieves.
Tabletting slice weight is 0.8g/ piece in the step 7).
Embodiment 6:
1) the hydroxypropyl methyl cellulose wetting agent that mass fraction is 0.8% is prepared;
2) the haematococcus pluvialis algae powder of 8.0 parts by weight, the isomalt of 20.0 parts by weight, 10.0 parts by weight are weighed
Collagen protein powder, the butter fruit powder of 3.0 parts by weight, the Acerola cherry fruit powder of 3.0 parts by weight, the Cranberry fruit powder of 3.0 parts by weight,
The blueberry powder of 3.0 parts by weight, the oligofructose of 10.0 parts by weight, the stachyose of 2.0 parts by weight, 2.0 parts by weight inulin,
The sodium citrate of 0.2 parts by weight crosses 80 mesh standard sieves, after mixing, hydroxypropyl methyl cellulose wetting agent, hydroxypropyl is added
Ylmethyl cellulose wetting agent dosage is 15 parts by weight, is uniformly mixed;
3) material being uniformly mixed is granulated;
4) particle prepared vacuum oven is put into dry;
5) by the dry powder collection completed, whole grain is carried out;
6) magnesium stearate of 0.5 parts by weight is weighed, and the particle completed with whole grain is mixed, incorporation time 12min;
7) material mixed is put into tablet press machine, pressure 50KN carries out tabletting.
The ethanol-water system that hydroxypropyl methyl cellulose wetting agent solvent in the step 1) is 60%.
Granulation in the step 3) uses 20 mesh standard sieves.
Drying temperature in the step 4) is 60 DEG C, and pressure is -0.08MPa, time 3h.
Whole grain in the step 5) uses 20 mesh standard sieves.
Tabletting slice weight is 0.5g/ piece in the step 7).
Embodiment 7:
1) the hydroxypropyl methyl cellulose wetting agent that mass fraction is 1.8% is prepared;
2) the haematococcus pluvialis algae powder of 12.0 parts by weight, the isomalt of 30.0 parts by weight, 20.0 parts by weight are weighed
Collagen protein powder, the butter fruit powders of 8.0 parts by weight, the Acerola cherry fruit powder of 8.0 parts by weight, 8.0 parts by weight Cranberry fruit
Powder, the blueberry powder of 8.0 parts by weight, the oligofructose of 15.0 parts by weight, the stachyose of 4.0 parts by weight, 4.0 parts by weight chrysanthemum
The sodium citrate of powder, 0.3 parts by weight crosses 80 mesh standard sieves, after mixing, hydroxypropyl methyl cellulose wetting agent is added,
Hydroxypropyl methyl cellulose wetting agent dosage is 25 parts by weight, is uniformly mixed;
3) material being uniformly mixed is granulated;
4) particle prepared vacuum oven is put into dry;
5) by the dry powder collection completed, whole grain is carried out;
6) magnesium stearate of 1.2 parts by weight is weighed, and the particle completed with whole grain is mixed, incorporation time 13min;
7) material mixed is put into tablet press machine, pressure 60KN carries out tabletting.
The ethanol-water system that hydroxypropyl methyl cellulose wetting agent solvent in the step 1) is 80%.
Granulation in the step 3) uses 20 mesh standard sieves.
Drying temperature in the step 4) is 70 DEG C, and pressure is -0.06MPa, time 5h.
Whole grain in the step 5) uses 20 mesh standard sieves.
Tabletting slice weight is 0.7g/ piece in the step 7).
Finally, it should be noted that above embodiments are only to illustrate the present invention and not limit technology described in the invention
Scheme;Therefore, although this specification is referring to above-mentioned each embodiment, the present invention has been described in detail, this
Field it is to be appreciated by one skilled in the art that still can modify to the present invention or equivalent replacement;And all do not depart from this
The technical solution and its improvement of the spirit and scope of invention, should all cover within the scope of the claims of the present invention.
Claims (9)
1. a kind of pressed candy containing Astaxanthin In Haematococcus Pluvialis conditioning female organism, which is characterized in that including following weight
The component of part:
2. the pressed candy as described in claim 1 containing Astaxanthin In Haematococcus Pluvialis conditioning female organism, which is characterized in that
Component including following parts by weight:
3. a kind of pressed candy prepared as claimed in claim 1 or 2 containing Astaxanthin In Haematococcus Pluvialis conditioning female organism
Method, which is characterized in that comprising steps of
1) the hydroxypropyl methyl cellulose wetting agent that mass fraction is 0.5%~2.0% is prepared;
2) weigh the haematococcus pluvialis algae powder of 5.0~15.0 parts by weight, the isomalt of 15.0~40.0 parts by weight, 5~
The collagen protein powder of 30.0 parts by weight, the butter fruit powder of 1.0~10.0 parts by weight, the Acerola cherry fruit of 1.0~10.0 parts by weight
Powder, the Cranberry fruit powder of 1.0~10.0 parts by weight, the blueberry powder of 1.0~10.0 parts by weight, 5.0~20.0 parts by weight it is low
Fructooligosaccharides, the stachyose of 0.5~5.0 parts by weight, the inulin of 0.5~5.0 parts by weight, 0.1~0.5 parts by weight sodium citrate,
80 mesh standard sieves are crossed, after mixing, hydroxypropyl methyl cellulose wetting agent are added, hydroxypropyl methyl cellulose wetting agent is used
Amount is 10~30 parts by weight, is uniformly mixed;
3) material being uniformly mixed is granulated;
4) particle prepared vacuum oven is put into dry;
5) by the dry powder collection completed, whole grain is carried out;
6) magnesium stearate of 0.1~1.5 parts by weight is weighed, and the particle completed with whole grain is mixed, incorporation time 10min~
15min;
7) material mixed is put into tablet press machine, pressure is 40~70KN, carries out tabletting.
4. the method for pressed candy of the preparation as claimed in claim 3 containing Astaxanthin In Haematococcus Pluvialis conditioning female organism,
It is characterized by: weighing the haematococcus pluvialis algae powder of 8.0~12.0 parts by weight;The isomaltoketose of 20.0~30.0 parts by weight
Alcohol;The needle cherry of the collagen protein powder of 10~20.0 parts by weight, the butter fruit powder of 3.0~8.0 parts by weight, 3.0~8.0 parts by weight
Peach fruit powder, the Cranberry fruit powder of 3.0~8.0 parts by weight, the blueberry powders of 3.0~8.0 parts by weight, 10.0~15.0 parts by weight
Oligofructose, the stachyose of 2.0~4.0 parts by weight, the inulin of 2.0~4.0 parts by weight, 0.2~0.3 parts by weight citric acid
The magnesium stearate of sodium, 0.5~1.2 parts by weight.
5. the method for pressed candy of the preparation as claimed in claim 3 containing Astaxanthin In Haematococcus Pluvialis conditioning female organism,
It is characterized by: the ethanol-water system that the hydroxypropyl methyl cellulose wetting agent solvent in the step 1) is 50%~90%.
6. the method for pressed candy of the preparation as claimed in claim 3 containing Astaxanthin In Haematococcus Pluvialis conditioning female organism,
It is characterized by: the granulation in the step 3) uses 20 mesh standard sieves.
7. the method for pressed candy of the preparation as claimed in claim 3 containing Astaxanthin In Haematococcus Pluvialis conditioning female organism,
It is characterized by: drying temperature in the step 4) is 50~80 DEG C, pressure is -0.09MPa~-0.05MPa, the time 2~
6h。
8. the method for pressed candy of the preparation as claimed in claim 3 containing Astaxanthin In Haematococcus Pluvialis conditioning female organism,
It is characterized by: the whole grain in the step 5) uses 20 mesh standard sieves.
9. the method for pressed candy of the preparation as claimed in claim 3 containing Astaxanthin In Haematococcus Pluvialis conditioning female organism,
It is characterized by: tabletting slice weight is 0.4~0.8g/ piece in the step 7).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811202442.9A CN109007224A (en) | 2018-10-16 | 2018-10-16 | A kind of pressed candy and preparation method thereof containing Astaxanthin In Haematococcus Pluvialis conditioning female organism |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811202442.9A CN109007224A (en) | 2018-10-16 | 2018-10-16 | A kind of pressed candy and preparation method thereof containing Astaxanthin In Haematococcus Pluvialis conditioning female organism |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109007224A true CN109007224A (en) | 2018-12-18 |
Family
ID=64613280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811202442.9A Pending CN109007224A (en) | 2018-10-16 | 2018-10-16 | A kind of pressed candy and preparation method thereof containing Astaxanthin In Haematococcus Pluvialis conditioning female organism |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109007224A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109662234A (en) * | 2019-01-17 | 2019-04-23 | 云南龙布瑞生物科技有限公司 | A kind of Astaxanthin In Haematococcus Pluvialis solid beverage adjusting women skin, anti-aging |
CN110771900A (en) * | 2019-11-08 | 2020-02-11 | 邹伟岗 | Bird's nest prebiotics collagen peptide jelly |
CN111588027A (en) * | 2020-04-21 | 2020-08-28 | 富诺健康股份有限公司 | Composition containing anthocyanin and preparation method and application thereof |
CN112842967A (en) * | 2021-03-05 | 2021-05-28 | 广州正广生物科技有限公司 | Anti-aging composition with function of removing free radicals and preparation method thereof |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20000045197A (en) * | 1998-12-30 | 2000-07-15 | 서경배 | Healthy nutrition composition containing chitosanoligosaccharide and astaxanthin |
CN102228176A (en) * | 2011-05-19 | 2011-11-02 | 北京康比特体育科技股份有限公司 | Composition for increasing immunity and its preparation method |
CN104770636A (en) * | 2015-03-03 | 2015-07-15 | 青岛森淼实业有限公司 | Nutritional supplement containing astaxanthin and prebiotics and press candy prepared from same |
CN105581332A (en) * | 2015-12-31 | 2016-05-18 | 石家庄中硕药业有限公司 | Composition with skin moisture improving and antioxidation functions and preparation method |
CN105725184A (en) * | 2016-02-02 | 2016-07-06 | 北京同仁堂健康药业股份有限公司 | Composition containing haematococcus pluvialis and collagen and preparing method thereof |
CN106215173A (en) * | 2016-08-15 | 2016-12-14 | 宁波君瑞生物科技有限公司 | A kind of have the tablet improving women skin state effect |
CN107549812A (en) * | 2017-10-16 | 2018-01-09 | 海南三元星生物科技股份有限公司 | It is a kind of using acerola concentrate extract, haematococcus pluvialis and Isin glue collagen peptide as beautifying and anti-aging food of raw material and preparation method thereof |
-
2018
- 2018-10-16 CN CN201811202442.9A patent/CN109007224A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20000045197A (en) * | 1998-12-30 | 2000-07-15 | 서경배 | Healthy nutrition composition containing chitosanoligosaccharide and astaxanthin |
CN102228176A (en) * | 2011-05-19 | 2011-11-02 | 北京康比特体育科技股份有限公司 | Composition for increasing immunity and its preparation method |
CN104770636A (en) * | 2015-03-03 | 2015-07-15 | 青岛森淼实业有限公司 | Nutritional supplement containing astaxanthin and prebiotics and press candy prepared from same |
CN105581332A (en) * | 2015-12-31 | 2016-05-18 | 石家庄中硕药业有限公司 | Composition with skin moisture improving and antioxidation functions and preparation method |
CN105725184A (en) * | 2016-02-02 | 2016-07-06 | 北京同仁堂健康药业股份有限公司 | Composition containing haematococcus pluvialis and collagen and preparing method thereof |
CN106215173A (en) * | 2016-08-15 | 2016-12-14 | 宁波君瑞生物科技有限公司 | A kind of have the tablet improving women skin state effect |
CN107549812A (en) * | 2017-10-16 | 2018-01-09 | 海南三元星生物科技股份有限公司 | It is a kind of using acerola concentrate extract, haematococcus pluvialis and Isin glue collagen peptide as beautifying and anti-aging food of raw material and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
姚静: "《药用辅料应用指南》", 31 August 2011, 中国医药科技出版社 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109662234A (en) * | 2019-01-17 | 2019-04-23 | 云南龙布瑞生物科技有限公司 | A kind of Astaxanthin In Haematococcus Pluvialis solid beverage adjusting women skin, anti-aging |
CN110771900A (en) * | 2019-11-08 | 2020-02-11 | 邹伟岗 | Bird's nest prebiotics collagen peptide jelly |
CN111588027A (en) * | 2020-04-21 | 2020-08-28 | 富诺健康股份有限公司 | Composition containing anthocyanin and preparation method and application thereof |
CN112842967A (en) * | 2021-03-05 | 2021-05-28 | 广州正广生物科技有限公司 | Anti-aging composition with function of removing free radicals and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109007224A (en) | A kind of pressed candy and preparation method thereof containing Astaxanthin In Haematococcus Pluvialis conditioning female organism | |
CN102188565B (en) | Weight-losing soft capsules and preparation method thereof | |
CN103431134A (en) | Tablet candy containing prebiotics and preparation method thereof | |
CN101731622A (en) | Lucid ganoderma spirulina tablet and preparation process thereof | |
CN102960520B (en) | L-arabinose health-care press candy added with cyclocarya paliurus | |
CN104489697A (en) | Mannan-oligosaccharide-containing meal replacement powder with health function and preparation method of mannan-oligosaccharide-containing meal replacement powder | |
CN107183688A (en) | A kind of plant composite enzyme and preparation method thereof | |
CN102349608A (en) | Healthcare product combination for clearing and nourishing throat and preparation method thereof | |
CN102274271B (en) | Soybean plantworms mycelium powder and preparation method thereof | |
CN101711542A (en) | Production method of buckwheat rutin tea | |
CN103340356B (en) | Health care wheat germ chewable tablet and production technology thereof | |
WO2019100540A1 (en) | Method for preparing litopenaeusvannamei feed additive | |
CN108523001A (en) | A kind of natto powder and its production technology | |
CN112674334A (en) | Whitening, beautifying and anti-saccharification blueberry powder compound solid preparation as well as preparation method and application thereof | |
CN109007226A (en) | A kind of Astaxanthin In Haematococcus Pluvialis pectase pressed candy and preparation method thereof | |
JP2002209553A (en) | Carcinostatic healthy food and additive for healthy food | |
CN109007225A (en) | A kind of brown alga astaxanthin pressed candy and preparation method thereof | |
CN108967900A (en) | A kind of selenium-rich salubrity powder and preparation method thereof | |
CN108208813A (en) | A kind of weight-reducing with health role disappears fat piece and preparation method thereof | |
CN109170154A (en) | The preparation method of the deer health-care feed of strengthen immunity | |
US20220305069A1 (en) | A preparation method of antrodia cinnamomea water-insoluble dietary fiber | |
CN107136490A (en) | A kind of peptide Chinese caterpillar fungus health product | |
CN108323762B (en) | Selenium-rich composition and preparation, preparation method and application thereof | |
CN1718101A (en) | Tablets contg. bee-pollen and soybean ovolecithin, and its prodn. method | |
CN1321587C (en) | Snail health product and its preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181218 |